Author:
Lamotte Guillaume,Foster Norman L.
Publisher
Springer International Publishing
Reference92 articles.
1. Biomarker Working Group F-NB. Biomarkers, endpoints, and other tools. In: Spring S, editor. BEST (biomarkers, endpoints, and other tools). Silver Spring: FDA-NIH; 2016.
2. Herzog R, Elgort DR, Flanders AE, Moley PJ. Variability in diagnostic error rates of 10 MRI centers performing lumbar spine MRI examinations on the same patient within a 3-week period. Spine J. 2017;17(4):554–61.
3. Suárez J, Tartaglia MC, Vitali P, Erbetta A, Neuhaus J, Laluz V, et al. Characterizing radiology reports in patients with frontotemporal dementia. Neurology. 2009;73(13):1073–4.
4. Kinahan PE, Perlman ES, Sunderland JJ, Subramaniam R, Wollenweber SD, Turkington TG, et al. The QIBA profile for FDG PET/CT as an imaging biomarker measuring response to cancer therapy. Radiology. 2020;294(3):647–57.
5. Skillbäck T, Rosén C, Asztely F, Mattsson N, Blennow K, Zetterberg H. Diagnostic performance of cerebrospinal fluid total tau and phosphorylated tau in Creutzfeldt-Jakob disease: results from the Swedish Mortality Registry. JAMA Neurol. 2014;71(4):476–83.